Government Briefs

For the second time in three years, the Presidential Young investigator Awards program has been scaled back. Because of NSF’s tight budget only 148 scientists of the planned 200 were selected. In 1986 only half of the scheduled 200 were funded. The five-year-old federal effort is designed to keep new Ph.D.s from leaving academia for industry by providing them with up to $37,500 annually, for five years, as well as an annual $25,000 Stipend. The catch is that these are matching funds, and

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

For the second time in three years, the Presidential Young investigator Awards program has been scaled back. Because of NSF’s tight budget only 148 scientists of the planned 200 were selected. In 1986 only half of the scheduled 200 were funded. The five-year-old federal effort is designed to keep new Ph.D.s from leaving academia for industry by providing them with up to $37,500 annually, for five years, as well as an annual $25,000 Stipend. The catch is that these are matching funds, and the scientists must first snare money from industrial or foundation sponsors. Engineers and other applied scientists have had a good track record. But others—for example, mathematicians—have found it hard to convince industry to chip in.

The Reagan administration is no longer receiving annual briefings from the National Research Council on hot research topics. Begun in 1983 at the behest of presidential science adviser George Keyworth, panels of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies